Dr. Westin on Emerging PARP Inhibitors in Ovarian Cancer
November 20th 2018Shannon N. Westin, MD, MPH, clinical investigator, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, discusses PARP inhibitors being tested in clinical trials.
Read More
Dr. Westin on PARP Resistance in Ovarian Cancer
October 9th 2018Shannon N. Westin, MD, MPH, clinical investigator, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, discusses resistance to PARP inhibitors in patients with ovarian cancer.
Read More